News
Allowance to extend into 2036 patent claims related to method of treating patients with A-T using the company’s proprietary EryDex process Charles Ryan, J.D., Ph.D., Quince’s President and ...
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback